跳至主要内容
临床试验/NCT01626989
NCT01626989已完成不适用

Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders.

Philips Respironics6 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2010年6月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
6
主要终点
Apnea-Hypopnea Index (AHI)

研究概览

简要总结

Comparing two BiPAP autoSV devices in participants with complex sleep apnea and determining if the new device will treat those participants no worse than when compared to its predecessor device.

详细描述

The use of the BiPAP autoSV4 device in participants with Complex Sleep Apnea Syndrome will treat those participants no worse than when compared to its predecessor device, the BiPAP autoSV Advanced™, with respect to:

• Apnea-Hypopnea Index (AHI)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
21 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 21-80
  • Ability to provide consent
  • Documentation of medical stability by investigator
  • Subjects who currently have been on Positive Airway Pressure (PAP) therapy for ≥ 4 weeks and who previously had a Continuous Positive Airway Pressure (CPAP) titration with CAI ≥
  • OR Subjects who currently have been on PAP therapy for ≥ 4 weeks and who had a diagnostic study done, with a CAI ≥ 5, and were prescribed PAP therapy without a CPAP titration.
  • Agreement to undergo a full-night, in-lab research CPAP Titration
  • Agreement to undergo two full-night, in-lab therapy research Polysomnography (PSG) on BiPAP autoSV devices

排除标准

  • Major medical or psychiatric condition that would interfere with the demands of the study, adherence to positive airway pressure, or the ability to complete the study. For example, unstable congestive heart failure, chronic lung disease, neuromuscular disease, daytime hypercapnia, cancer, or renal failure.
  • Systolic blood pressure < 80 mm Hg at Baseline Visit.
  • Participants in whom PAP therapy is otherwise medically contraindicated.
  • Participants who are unwilling to wear CPAP
  • Currently prescribed oxygen therapy (as needed, nocturnal, or continuous
  • Participants with previously diagnosed respiratory failure or respiratory insufficiency and who are known to have chronically elevated arterial carbon dioxide levels while awake (PaCO2 ≥ 45mmHg).
  • Participants who have had surgery of the upper airway, nose, sinus, or middle ear within the previous 90 days.
  • Participants with untreated, non-obstructive Sleep Apnea (OSA)/ Complex Sleep Apnea (CSA) sleep disorders, including but not limited to; insomnia, periodic limb movement syndrome, or restless legs syndrome (PLM Arousal Index > 15).

研究组 & 干预措施

BiPAP auto SV Advanced

Active Comparator

BiPAP auto SV Advanced

干预措施: BiPAP auto Advanced (Device)

BiPAP auto SV 4

Experimental

Auto Servo Ventilation Device

干预措施: BiPAP auto SV4 (Device)

结局指标

主要结局

Apnea-Hypopnea Index (AHI)

时间窗: Baseline, and 2 nights (1 night for each intervention)

Apnea-Hypopnea Index (AHI) is the number of apneas and hypopneas per hour of sleep.

次要结局

  • Non Rapid Eye Movement (NREM) and Rapid Eye Movement (REM) Percentage Based on Total Sleep Time (TST) Indices(Baseline, and 2 nights (1 night for each intervention))
  • Obstructive Apnea Index (OAI)(Baseline, and 2 nights (1 night for each intervention))
  • REM Onset Latency (ROL)(Baseline, and 2 nights (1 night for each intervention))
  • Wake After Sleep Onset (WASO)(Baseline, and 2 nights (1 night for each intervention))
  • Sleep Onset Latency (SOL)(Baseline, and 2 nights (1 night for each intervention))
  • Sleep Efficiency (SE %)(Baseline, and 2 nights (1 night for each intervention))
  • Hypopnea Index (HI)(Baseline, and 2 nights (1 night for each intervention))
  • Central Apnea Index(CAI)(Baseline, and 2 nights (1 night for each intervention))
  • Wake (W), Stages N1,N2,N3 (NREM), and REM (R) Sleep(Baseline, and 2 nights (1 night for each intervention))
  • Arousal Index(Baseline, and 2 nights (1 night for each intervention))
  • Mixed Apnea Index (MAI)(Baseline, and 2 nights (1 night for each intervention))
  • Total Sleep Time (TST)(Baseline, and 2 nights (1 night for each intervention))
  • Nocturnal Oxygenation(Baseline, and 2 nights (1 night for each intervention))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验